Alexei N. Plotnikov

4.9k total citations · 1 hit paper
51 papers, 3.3k citations indexed

About

Alexei N. Plotnikov is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Internal Medicine. According to data from OpenAlex, Alexei N. Plotnikov has authored 51 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Cardiology and Cardiovascular Medicine, 14 papers in Molecular Biology and 7 papers in Internal Medicine. Recurrent topics in Alexei N. Plotnikov's work include Cardiac electrophysiology and arrhythmias (21 papers), Atrial Fibrillation Management and Outcomes (19 papers) and Antiplatelet Therapy and Cardiovascular Diseases (12 papers). Alexei N. Plotnikov is often cited by papers focused on Cardiac electrophysiology and arrhythmias (21 papers), Atrial Fibrillation Management and Outcomes (19 papers) and Antiplatelet Therapy and Cardiovascular Diseases (12 papers). Alexei N. Plotnikov collaborates with scholars based in United States, Germany and Netherlands. Alexei N. Plotnikov's co-authors include Peter Danilo, Michael R. Rosen, Paul Burton, Iryna N. Shlapakova, C. Michael Gibson, Eugene Braunwald, Jessica L. Mega, Christoph Bode, Sabina A. Murphy and Xiang Sun and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Alexei N. Plotnikov

49 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rivaroxaban in Patients with a Recent Acute Coronary Syndrome

2011 1.3k citations Jessica L. Mega, Eugene Braunwald et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alexei N. Plotnikov United States	26	2.8k	831	820	491	393	51	3.3k
W J Penny United Kingdom	22	1.1k 0.4×	223 0.3×	283 0.3×	491 1.0×	78 0.2×	45	1.7k
Yasuya Inden Japan	30	2.9k 1.0×	526 0.6×	162 0.2×	312 0.6×	32 0.1×	191	3.7k
Yukihiro Koretsune Japan	23	2.0k 0.7×	285 0.3×	568 0.7×	241 0.5×	76 0.2×	62	2.5k
Stephan H. Schirmer Germany	28	1.4k 0.5×	523 0.6×	165 0.2×	543 1.1×	26 0.1×	82	2.4k
Boris Aleil France	11	565 0.2×	161 0.2×	243 0.3×	505 1.0×	53 0.1×	22	1.3k
Isabelle C. Van Gelder Netherlands	26	2.6k 0.9×	472 0.6×	116 0.1×	155 0.3×	52 0.1×	68	3.0k
Klaus Hallermayer Germany	11	1.6k 0.5×	210 0.3×	109 0.1×	432 0.9×	118 0.3×	18	2.0k
J. E. Lowe United States	16	1.9k 0.7×	341 0.4×	66 0.1×	738 1.5×	57 0.1×	40	2.8k
Yüng-Zu Tseng Taiwan	28	1.9k 0.7×	646 0.8×	33 0.0×	274 0.6×	72 0.2×	86	2.5k
Rasmus Havmoeller United States	4	3.0k 1.1×	177 0.2×	365 0.4×	175 0.4×	22 0.1×	4	3.3k

Countries citing papers authored by Alexei N. Plotnikov

Since Specialization

Citations

This map shows the geographic impact of Alexei N. Plotnikov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexei N. Plotnikov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexei N. Plotnikov more than expected).

Fields of papers citing papers by Alexei N. Plotnikov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexei N. Plotnikov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexei N. Plotnikov. The network helps show where Alexei N. Plotnikov may publish in the future.

Co-authorship network of co-authors of Alexei N. Plotnikov

This figure shows the co-authorship network connecting the top 25 collaborators of Alexei N. Plotnikov. A scholar is included among the top collaborators of Alexei N. Plotnikov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexei N. Plotnikov. Alexei N. Plotnikov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gibson, C. Michael, Maria Cecilia Bahit, Roxana Mehran, et al.. (2025). Oral factor xia inhibitor milvexian after a recent acute coronary syndrome: Rationale and design of the phase 3 (Librexia ACS). American Heart Journal. 285. 21–28. 4 indexed citations

Korjian, Serge, Eugene Braunwald, Yazan Daaboul, et al.. (2018). Usefulness of Rivaroxaban for Secondary Prevention of Acute Coronary Syndrome in Patients With History of Congestive Heart Failure (from the ATLAS-ACS-2 TIMI-51 Trial). The American Journal of Cardiology. 122(11). 1896–1901. 18 indexed citations

Kernéis, Mathieu, Tarek Nafee, Megan K. Yee, et al.. (2018). D-Dimer Levels and Effect of Rivaroxaban on Those Levels and Outcomes in Patients With Acute Coronary Syndrome (An ATLAS ACS-TIMI 46 Trial Substudy). The American Journal of Cardiology. 122(9). 1459–1464. 26 indexed citations

Povsic, Thomas J., Matthew T. Roe, E. Magnus Ohman, et al.. (2016). A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II study. American Heart Journal. 174. 120–128. 23 indexed citations

Braunwald, Eugene, Sabina A. Murphy, Alexei N. Plotnikov, et al.. (2014). RIVAROXABAN IN PATIENTS STABILIZED AFTER A ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION. RESULTS FROM THE ATLAS ACS-2–TIMI-51 TRIAL. Rational Pharmacotherapy in Cardiology. 10(2). 245–252. 2 indexed citations

Mega, Jessica L., Eugene Braunwald, Sabina A. Murphy, et al.. (2013). RIVAROXABAN IN THE SETTING OF CONTINUED DUAL ANTIPLATELET THERAPY: FINDINGS FROM THE ATLAS ACS 2-TIMI 51 TRIAL. Journal of the American College of Cardiology. 61(10). E4–E4. 2 indexed citations

Mega, Jessica L., Eugene Braunwald, Stephen D. Wiviott, et al.. (2013). Comparison of the Efficacy and Safety of Two Rivaroxaban Doses in Acute Coronary Syndrome (from ATLAS ACS 2–TIMI 51). The American Journal of Cardiology. 112(4). 472–478. 35 indexed citations

Xu, Xu Steven, Kenneth Todd Moore, Paul Burton, et al.. (2012). Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with acute coronary syndromes. British Journal of Clinical Pharmacology. 74(1). 86–97. 45 indexed citations

Moore, Kenneth Todd, et al.. (2011). Effect of Multiple Doses of Omeprazole on the Pharmacokinetics, Pharmacodynamics, and Safety of a Single Dose of Rivaroxaban. Journal of Cardiovascular Pharmacology. 58(6). 581–588. 47 indexed citations

10.

Gheorghiade, Mihai, Venkatesh Nadar, Barry Greenberg, et al.. (2010). Pharmacokinetics and pharmacodynamics of rivaroxaban and its effect on biomarkers of hypercoagulability in patients with chronic heart failure. The Journal of Heart and Lung Transplantation. 30(2). 218–226. 26 indexed citations

11.

Weinstein, Rachel, John H. Zhang, Mei Cheng, et al.. (2010). Antithrombotic therapies in patients with heart failure: hypothesis formulation from a research database. Pharmacoepidemiology and Drug Safety. 19(9). 911–920. 3 indexed citations

12.

Özgen, Nazira, Alexei N. Plotnikov, Iryna N. Shlapakova, et al.. (2007). Abstract 508: A Reactive Oxygen Species-mediated PKC-ERK-RSK Pathway Decreases The Cyclic AMP Response Element Binding Protein And May Initiate Transcriptional Changes In Cardiac Memory. Circulation. 116. 3 indexed citations

13.

Plotnikov, Alexei N., Annalisa Bucchi, Iryna N. Shlapakova, et al.. (2007). HCN212-channel biological pacemakers manifesting ventricular tachyarrhythmias are responsive to treatment with If blockade. Heart Rhythm. 5(2). 282–288. 49 indexed citations

14.

Chandra, Charu, Tove S. Rosen, Bengt Herweg, et al.. (2005). Atrial gradient as a potential predictor of atrial fibrillation. Heart Rhythm. 2(4). 404–410. 5 indexed citations

15.

Patberg, Kornelis W., Alexei Shvilkin, Alexei N. Plotnikov, et al.. (2005). Cardiac memory: Mechanisms and clinical implications. Heart Rhythm. 2(12). 1376–1382. 41 indexed citations

16.

Plotnikov, Alexei N., et al.. (2005). Prominent positive U waves appearing with high-dose intravenous phenylephrine. Journal of Electrocardiology. 38(4). 378–382. 2 indexed citations

17.

Patberg, Kornelis W., Sarah F. Giardina, Aviva J. Symes, et al.. (2005). The cAMP response element binding protein modulates expression of the transient outward current: Implications for cardiac memory. Cardiovascular Research. 68(2). 259–267. 34 indexed citations

18.

Rosen, M R & Alexei N. Plotnikov. (2002). The pharmacology of cardiac memory. Pharmacology & Therapeutics. 94(1-2). 63–75. 6 indexed citations

19.

Patel, Pravina M., Alexei N. Plotnikov, Prapa Kanagaratnam, et al.. (2001). Altering Ventricular Activation Remodels Gap Junction Distribution in Canine Heart. Journal of Cardiovascular Electrophysiology. 12(5). 570–577. 65 indexed citations

20.

Plotnikov, Alexei N.. (2001). Interactions between antiarrhythmic drugs and cardiac memory. Cardiovascular Research. 50(2). 335–344. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact